Protective effect of phytoestrogens on nonalcoholic fatty liver disease in postmenopausal women

Non-alcoholic fatty liver disease (NAFLD) is a progressive metabolic disease characterized by hepatic steatosis, inflammation, and fibrosis that seriously endangers global public health. Epidemiological studies have shown that the incidence of non-alcoholic fatty liver disease in postmenopausal wome...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: ChenLu Zhao (VerfasserIn), JunHao Shi (VerfasserIn), DongFang Shang (VerfasserIn), Min Guo (VerfasserIn), Cheng Zhou (VerfasserIn), WenXia Zhao (VerfasserIn)
Format: Buch
Veröffentlicht: Frontiers Media S.A., 2023-08-01T00:00:00Z.
Schlagworte:
Online-Zugang:Connect to this object online.
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!

MARC

LEADER 00000 am a22000003u 4500
001 doaj_2372f2c6aaa64cbe89b5f06816f03f6d
042 |a dc 
100 1 0 |a ChenLu Zhao  |e author 
700 1 0 |a JunHao Shi  |e author 
700 1 0 |a DongFang Shang  |e author 
700 1 0 |a Min Guo  |e author 
700 1 0 |a Cheng Zhou  |e author 
700 1 0 |a WenXia Zhao  |e author 
245 0 0 |a Protective effect of phytoestrogens on nonalcoholic fatty liver disease in postmenopausal women 
260 |b Frontiers Media S.A.,   |c 2023-08-01T00:00:00Z. 
500 |a 1663-9812 
500 |a 10.3389/fphar.2023.1237845 
520 |a Non-alcoholic fatty liver disease (NAFLD) is a progressive metabolic disease characterized by hepatic steatosis, inflammation, and fibrosis that seriously endangers global public health. Epidemiological studies have shown that the incidence of non-alcoholic fatty liver disease in postmenopausal women has significantly increased. Studies have shown that estrogen deficiency is the main reason for this situation, and supplementing estrogen has become a new direction for preventing the occurrence of postmenopausal fatty liver. However, although classical estrogen replacement therapy can reduce the incidence of postmenopausal NAFLD, it has the risk of increasing stroke and cardiovascular diseases, so it is not suitable for the treatment of postmenopausal NAFLD. More and more recent studies have provided evidence that phytoestrogens are a promising method for the treatment of postmenopausal NAFLD. However, the mechanism of phytoestrogens in preventing and treating postmenopausal NAFLD is still unclear. This paper summarizes the clinical and basic research evidence of phytoestrogens and reviews the potential therapeutic effects of phytoestrogens in postmenopausal NAFLD from six angles: enhancing lipid metabolism in liver and adipose tissue, enhancing glucose metabolism, reducing oxidative stress, reducing the inflammatory response, regulating intestinal flora, and blocking liver fibrosis (Graphical Abstract). 
546 |a EN 
690 |a phytoestrogens(PEs) 
690 |a postmenopausal women 
690 |a non-alcoholic fatty liver disease 
690 |a lipid metabolism 
690 |a glucose metabolism 
690 |a oxidative stress 
690 |a Therapeutics. Pharmacology 
690 |a RM1-950 
655 7 |a article  |2 local 
786 0 |n Frontiers in Pharmacology, Vol 14 (2023) 
787 0 |n https://www.frontiersin.org/articles/10.3389/fphar.2023.1237845/full 
787 0 |n https://doaj.org/toc/1663-9812 
856 4 1 |u https://doaj.org/article/2372f2c6aaa64cbe89b5f06816f03f6d  |z Connect to this object online.